BIG PICTURE BIO LIMITED

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

BIG PICTURE BIO LIMITED - overview

Established

2026

Location

London, England, UK

Primary Industry

Biotechnology

About

Founded in 2026 and based in London, UK, Big Picture Bio provides an artificial intelligence platform and related services that predict and design drug combinations for cancer treatment, support trial outcome assessment, and help pharmaceutical and biotechnology companies evaluate combination therapy strategies.


Current Investors

Exceptional Ventures, Kadmos Capital, Gloucester Ventures

Primary Industry

Biotechnology

Sub Industries

Bioinformatics, Healthcare IT, Oncology/Cancer Treatment, Pharmaceutical Research & Development, Scientific Software

Website

www.bigpicturebio.com/

Verticals

Artificial Intelligence, HealthTech

Company Stage

Angel & Seed

Total Amount Raised

Subscriber access only

BIG PICTURE BIO LIMITED - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Unspecified RoundCompletedBIG PICTURE BIO LIMITED-
GrantCompletedBIG PICTURE BIO LIMITED-

Displaying 1 - 2 of 2

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.